To better understand the complex dynamics of TLR signaling and responses in the context of glioma progression, Hu et al. identified the glioma-derived endogenous factors that manipulated TLR2 in a mouse brain tumor slice model. The gene discussed is TLR2; the disease is central nervous system cancer.